Tech Company Financing Transactions

Alltrna Funding Round

Alltrna closed a $109 million Series B funding round on 8/9/2023. Investors included Flagship Pioneering.

Transaction Overview

Company Name
Announced On
8/9/2023
Transaction Type
Venture Equity
Amount
$109,000,000
Round
Series B
Investors

Flagship Pioneering (Michelle Werner)

Proceeds Purpose
The company intends to use the funds to advance its platform and first drug candidates towards the clinic for a first indication in Stop Codon Disease. Stop Codon Disease encompasses thousands of rare and common diseases that stem from premature termination codons (PTC) also called nonsense mutations, where the code for an amino acid has been mutated into a premature "stop" codon. This results in a truncated or shortened protein product with no or altered biological activity that causes disease. Approximately 10% of all people with a genetic disease have Stop Codon Disease, representing approximately 30 million people worldwide.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA 02114
USA
Phone
Undisclosed
Email Address
Overview
Alltrna unlocks tRNA biology to correct disease. The company's platform incorporates AI/ML tools to learn the tRNA language and deliver diverse programmable molecules with broad therapeutic potential. Alltrna has an unprecedented opportunity to advance a single tRNA medicine to unify treatment across a wide range of diseases with the same underlying genetic mutation.
Profile
Alltrna LinkedIn Company Profile
Social Media
Alltrna Company Twitter Account
Company News
Alltrna News
Facebook
Alltrna on Facebook
YouTube
Alltrna on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Lovisa Afzelius
  Lovisa Afzelius LinkedIn Profile  Lovisa Afzelius Twitter Account  Lovisa Afzelius News  Lovisa Afzelius on Facebook
Co-Founder
Theonie Anastassiadis
  Theonie Anastassiadis LinkedIn Profile  Theonie Anastassiadis Twitter Account  Theonie Anastassiadis News  Theonie Anastassiadis on Facebook
Vice President
William Kiesman
  William Kiesman LinkedIn Profile  William Kiesman Twitter Account  William Kiesman News  William Kiesman on Facebook
Vice President
Nikolai Naryshkin
  Nikolai Naryshkin LinkedIn Profile  Nikolai Naryshkin Twitter Account  Nikolai Naryshkin News  Nikolai Naryshkin on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/9/2023: Kore Labs venture capital transaction
Next: 8/9/2023: Halodoc venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary